Voiding Dysfunction VA Rating: 38 CFR 4.115a Criteria and Diagnostic Codes

The predominant dysfunction rule and anti-pyramiding (38 CFR 4.115a and 4.14)

The introductory paragraph of 38 CFR 4.115a states:

“Where diagnostic codes refer the decision maker to these specific areas of dysfunction, only the predominant area of dysfunction shall be considered for rating purposes. Distinct disabilities may be evaluated separately under this section, pursuant to § 4.14, if the symptoms do not overlap.”

This rule operates in two ways:

1. Single evaluation for the predominant symptom area: When one service-connected condition (such as BPH under DC 7527 or chronic cystitis under DC 7512) causes both urinary frequency and leakage, or both obstructed voiding and frequency, the VA assigns only the highest (predominant) evaluation. A veteran meeting the 20% frequency criteria and the 40% pad-change criteria receives a single 40% rating, not combined 20% and 40% ratings.
2. Separate ratings only for distinct non-overlapping diagnoses (38 CFR 4.14): Under 38 CFR 4.14, evaluating the same manifestation under multiple diagnoses is prohibited as pyramiding. However, when a veteran has two distinct service-connected genitourinary conditions with non-overlapping symptoms—such as upper tract kidney stones rated on renal colic under DC 7508/7509 and a lower tract bladder condition rated on pad changes under 38 CFR 4.115a, or erectile dysfunction under DC 7522 alongside voiding dysfunction—each condition is rated separately.

Breaking down the three voiding dysfunction rating formulas

1. Urine leakage and urinary incontinence (20%, 40%, and 60%)

The highest schedular percentages for voiding dysfunction—up to 60%—fall under “Continual Urine Leakage, Post Surgical Urinary Diversion, Urinary Incontinence, or Stress Incontinence.” This category covers urge incontinence, stress incontinence (common after prostate surgery or pelvic trauma), overflow incontinence, continual leakage from fistulae, and post-surgical urinary diversions (such as an ileal conduit or urostomy):

• Wearing and changing absorbent materials: Qualifying for 20%, 40%, or 60% based on absorbent pads, guards, shields, or adult briefs requires wearing absorbent materials and documenting daily changes: less than 2 times per day (1 pad worn and changed daily) warrants 20%, 2 to 4 times per day warrants 40%, and more than 4 times per day (5 or more changes daily) warrants 60%.
• Requiring the use of an appliance (60% rating): A 60% evaluation also applies when the condition requires a urinary appliance, such as an external condom catheter connected to a leg bag, an indwelling Foley or suprapubic catheter collection system, a urostomy pouching appliance, a penile incontinence clamp (Cunningham clamp), or an implanted artificial urinary sphincter (AUS).

Minor post-void dribbling that does not require wearing absorbent pads or using an appliance does not meet the 20% leakage threshold, though the condition may still be rated under urinary frequency or obstructed voiding.

2. Urinary frequency and nocturia (10%, 20%, and 40%)

When frequent urination is the primary impairment—as in overactive bladder, interstitial cystitis (DC 7512), BPH (DC 7527), or radiation cystitis—the VA evaluates the claim under Urinary Frequency:

• 10% rating: Daytime voiding interval between two and three hours, or awakening to void two times per night.
• 20% rating: Daytime voiding interval between one and two hours, or awakening to void three to four times per night.
• 40% rating: Daytime voiding interval less than one hour, or awakening to void five or more times per night.

Because each tier uses “or,” satisfying either the daytime interval or the nighttime awakening requirement earns that percentage. Waking from sleep 3 to 4 times per night to urinate (nocturia) warrants 20% even if daytime voiding occurs every 3 to 4 hours, and waking 5 or more times per night warrants 40%.

3. Obstructed voiding (0%, 10%, and 30%)

When blockage or detrusor underactivity at the bladder neck, prostate, or urethra prevents complete emptying, the VA evaluates the condition under Obstructed Voiding:

• 0% rating: Obstructive symptomatology with or without stricture disease requiring dilatation 1 to 2 times per year.
• 10% rating: Marked obstructive symptomatology (hesitancy, slow or weak stream, decreased force of stream) accompanied by any one or combination of four objective findings: (1) post-void residuals (PVR) greater than 150 cc; (2) uroflowmetry with a markedly diminished peak flow rate (less than 10 cc/sec); (3) recurrent urinary tract infections secondary to obstruction; or (4) stricture disease requiring periodic dilatation every 2 to 3 months.
• 30% rating: Urinary retention requiring intermittent or continuous catheterization (such as clean intermittent self-catheterization several times daily or an indwelling catheter).

Subjective complaints of a weak stream or hesitancy without catheterization or one of the four objective 10% findings warrant 0% under obstructed voiding—unless accompanying daytime frequency or nocturia qualifies for 10%, 20%, or 40% under urinary frequency.

Diagnostic codes in 38 CFR 4.115b that rate as voiding dysfunction

Eleven diagnostic codes in 38 CFR 4.115b direct adjudicators to rate the condition under the 38 CFR 4.115a voiding dysfunction criteria:

• Rated solely as voiding dysfunction: DC 7512 (Cystitis, chronic, includes interstitial and all etiologies, infectious and non-infectious), DC 7515 (Bladder, calculus in, with symptoms interfering with function), DC 7517 (Bladder, injury of), DC 7518 (Urethra, stricture of), and DC 7519 (Urethra, fistula of; multiple urethroperineal fistulae warrants 100%).
• Rated as voiding dysfunction or urinary tract infection, whichever is predominant: DC 7516 (Bladder, fistula of; postoperative suprapubic cystotomy warrants 100%), DC 7527 (Prostate gland injuries, infections, hypertrophy, postoperative residuals, bladder outlet obstruction), DC 7542 (Neurogenic bladder), and DC 7545 (Bladder, diverticulum of).
• Rated as voiding dysfunction or renal dysfunction, whichever is predominant: DC 7528 (Malignant neoplasms of the genitourinary system, including prostate cancer and bladder cancer, rated 100% during active disease/treatment plus 6 months, and on residuals thereafter) and DC 7529 (Benign neoplasms of the genitourinary system).

Effective November 14, 2021 (86 FR 54081), the VA revised 38 CFR 4.115b while keeping 38 CFR 4.115a voiding dysfunction criteria unchanged. The rule expanded DC 7512 to cover interstitial and non-infectious cystitis, added “bladder outlet obstruction” to DC 7527, and updated DC 7542 (and added DC 7545) to allow evaluation under voiding dysfunction or the Urinary Tract Infection formula in 38 CFR 4.115a (30% for recurrent infection requiring stent/nephrostomy drainage, >2 hospitalizations/year, or continuous intensive management; 10% for 1–2 hospitalizations/year or suppressive drug therapy ≥6 months; and 0% for suppressive therapy <6 months).

Establishing direct, secondary, and presumptive service connection

1. Direct service connection (38 CFR 3.303): Requires a current bladder, urethral, or prostate diagnosis causing voiding dysfunction, evidence of an in-service urological event or diagnosis (such as pelvic trauma, urethral stricture, recurrent cystitis, or BPH), and a medical nexus under 38 CFR 3.303.
2. Secondary service connection (38 CFR 3.310): Under 38 CFR 3.310(a), voiding dysfunction may be service connected secondarily when caused or chronically aggravated by:
   • Prostate Cancer (DC 7528): Radical prostatectomy and pelvic radiation frequently leave residual stress incontinence, frequency, or stricture rated under 38 CFR 4.115a after the 100% rating ends.
   • Back Pain and Radiculopathy (Neurogenic Bladder, DC 7542): Disc herniation, spinal stenosis, or spine surgery may impair sacral nerves (S2–S4) controlling the detrusor muscle and sphincter.
   • Diabetes Mellitus and TBI: Diabetic autonomic peripheral neuropathy (diabetic cystopathy) and TBI may impair bladder sensation or detrusor control.
   • Medications: Anticholinergics prescribed for PTSD or depression may cause retention, while diuretics for hypertension may aggravate frequency and nocturia. Conversely, chronic incontinence and nocturia may cause secondary depression or anxiety (38 CFR 4.130).
3. Presumptive service connection: Under 38 U.S.C. 1116(a)(2)(J), bladder cancer is a statutory presumptive Agent Orange disease, and under 38 CFR 3.307(a)(6) and 38 CFR 3.309(e), prostate cancer is a presumptive Agent Orange disease; additionally, under 38 CFR 3.307(a)(7) and 38 CFR 3.309(f)(8), bladder cancer is a presumptive Camp Lejeune disease. Post-treatment residuals under DC 7528 are rated under 38 CFR 4.115a.

What to expect at the C&P exam and on the Urinary Tract DBQ

During a VA Compensation and Pension (C&P) exam, the clinician completes either the Urinary Tract Conditions DBQ (for DC 7512, DC 7518, and DC 7542) or the Male Reproductive Organ Conditions (Including Prostate Cancer) DBQ (for DC 7527 and DC 7528), available on the VA Public DBQs page:

1. Diagnosis and nexus: Specific bladder, prostate, or neurogenic diagnosis and its link to service or a primary disability.
2. Appliance use and daily pad changes: Whether you require a urinary appliance or absorbent materials changed < 2 times/day (20%), 2 to 4 times/day (40%), or > 4 times/day (60%).
3. Daytime interval and nocturia: Daytime voiding interval (2 to 3 hours for 10%, 1 to 2 hours for 20%, or < 1 hour for 40%) and nightly awakenings (2 for 10%, 3 to 4 for 20%, or 5 or more for 40%).
4. Obstructed voiding metrics: Whether retention requires intermittent or continuous catheterization (30%), or whether marked obstructive symptoms are paired with post-void residuals > 150 cc, peak flow < 10 cc/sec, recurrent UTIs, or stricture dilatation every 2 to 3 months (10%).

How a voiding dysfunction rating combines with other VA ratings

Evaluations of 10%, 20%, 30%, 40%, or 60% under 38 CFR 4.115a combine with other service-connected disabilities under the 38 CFR 4.25 Combined Ratings Table. The bilateral factor under 38 CFR 4.26 does not apply. Model how a voiding dysfunction rating affects your overall pay with our VA combined rating calculator.

When to seek accredited help with your claim

If your claim was denied or underrated, consider working with a VA-accredited representative:

• Veterans Service Organizations (VSOs): Accredited representatives from the DAV, VFW, and American Legion assist with claims and appeals free of charge.
• VA-Accredited Claims Agents and Attorneys: Accredited professionals certified by the VA Office of General Counsel represent veterans in Supplemental Claims, Higher-Level Reviews, and Board appeals.

No representative can promise an outcome. Verify accreditation or locate free help through the VA Office of General Counsel Accreditation Search.